Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
The Lancet. Respiratory Medicine|September 1, 2020
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trialDinesh Khanna, Celia J F Lin, Daniel E Furst, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 16, 2019
Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over groupJ P Bilezikian, C J F Lin, J P Brown, et al.
Open Forum Infectious Diseases|January 13, 2022
Safety and Efficacy of Tocilizumab 4 or 8 mg/kg in Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019 Pneumonia: A Randomized Clinical TrialPrincy N Kumar, Jules Hernández-Sánchez, Sandra Nagel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 30, 2026
Prognostic value of volume-based metabolic parameters of [18F]FDG PET/CT in anaplastic thyroid carcinomaH I Coerts, O P Smit, J F Lin, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 24, 2015
The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension studyS Papapoulos, K Lippuner, C Roux, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|April 16, 2025
[Severity of SARS-CoV-2 infection in children with kidney disease undergoing immunosuppressive therapy]Y F Zhang, H H Yang, J Huang, et al.
Annals of the Rheumatic Diseases|October 26, 2017
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)Dinesh Khanna, Christopher P Denton, Celia J F Lin, et al.
Epidemiology and Infection|May 29, 2014
Seroprevalence of severe fever with thrombocytopenia syndrome virus in southeastern China and analysis of risk factorsJ M Sun, Y J Zhang, Z Y Gong, et al.
Climacteric : the Journal of the International Menopause Society|April 8, 2011
Estradiol 1 mg and drospirenone 2 mg as hormone replacement therapy in postmenopausal Chinese womenS-Q Lin, L-Z Sun, J-F Lin, et al.
Critical Care Medicine|October 6, 2021
Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled TrialJennifer Tom, Min Bao, Larry Tsai, et al.
Pageof 7